Association of Type D Personality to Perceived Side Effects and Adherence in CPAP-treated Patients with OSAS
Overview
Affiliations
Continuous positive airway pressure (CPAP) is the treatment of choice for obstructive sleep apnoea syndrome (OSAS), but side effects are common and long-term adherence low. The Type D (distressed) personality is defined as a combination of negative affectivity and social inhibition. The association of Type D personality with adherence has not been studied in CPAP-treated patients with OSAS. This study aimed to describe the prevalence of Type D personality in OSAS patients with CPAP treatment longer than 6 months and the association with self-reported side effects and adherence. A cross-sectional descriptive design was used. A total of 247 OSAS patients with a mean use of CPAP treatment for 55 months (6-182 months) were included. Data collection was achieved by two questionnaires; the Type D scale 14 (DS14) (Type D personality), SECI (side effects of CPAP), as well as from medical records (clinical variables and objective adherence to CPAP treatment). Type D personality occurred in 30% of the patients with OSAS and significantly (P < 0.05-0.001) increased the perceived frequency and severity of a broad range of side effects. The objective adherence was significantly lower (P < 0.001) for OSAS patients with Type D compared to OSAS patients without Type D, both with regard to a mean use of 4 h per night and 85% of the self-rated sleep time per night. The additional effect of a Type D personality on perceived side effects and adherence to CPAP treatment found in this study could be used by healthcare personnel when evaluating patients waiting for treatment.
REM-predominant obstructive sleep apnea: an unmet clinical need.
Wellekens S, Vanderhelst E, Verbanck S, De Weerdt S Sleep Breath. 2025; 29(1):97.
PMID: 39934482 DOI: 10.1007/s11325-025-03268-5.
Chiang T, Hsu Y, Chern Y, Liao C, Tsai W, Hsieh P Cancer Med. 2024; 13(3):e7022.
PMID: 38400678 PMC: 10891461. DOI: 10.1002/cam4.7022.
De Weerdt S, Schotte C, Barbe K, Verbanck S, Verbraecken J Sleep Breath. 2023; 28(1):69-78.
PMID: 37418222 DOI: 10.1007/s11325-023-02859-4.
Factors associated with treatment adherence to mandibular advancement devices: a scoping review.
van der Hoek L, Rosenmoller B, van de Rijt L, de Vries R, Aarab G, Lobbezoo F Sleep Breath. 2023; 27(6):2527-2544.
PMID: 37386300 PMC: 10656313. DOI: 10.1007/s11325-023-02862-9.
Rychter A, Miniszewska J, Gora-Tybor J Biopsychosoc Med. 2023; 17(1):1.
PMID: 36658586 PMC: 9854114. DOI: 10.1186/s13030-023-00261-w.